{"ticker": {"uuid": "a3e254f9-5e51-4597-998b-c54bf89cc2a6", "symbol": "603229", "name": "Zhejiang Ausun Pharmaceutical Co., Ltd.", "exchange": "SHH", "country": "CN", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Enterprise value to EBIT forward of Zhejiang Ausun Pharmaceutical Co., Ltd. Class A \u2013 SSE:603229", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUWNHWnRpUXZBSnZrcjBzc2JDc3BiOG0wVEUtcWtfZWpYbFdRNEFEazU2Ylg2T0ZkcE41ajk3cVlQUUxHVGtIdDVfR0d3Ny1hclh0RTBHeFNhT1RaQ3NLUEtNVzJ6azlPRlM3WThJQkFPbnBqb0hwUEEyWlZkVUtkQml5WVVmazFnVS04OG9SeW1OSWs0anVrR0RmUjFQSVRycGtvWC01bEVoQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-16T00:41:52+00:00", "published_display": "16 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Zhejiang Ausun Pharmaceutical Co., Ltd. Class A \u2013 SSE:603229", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQWno3X1VkbFRtckZfS2xRNHdEWUUyNDZmZzJDbkVKWm1OalQtT0NDb2wwRFlCR2pZRHBWbHlWUXBxTmRDbTVFX1VZZjMwSVVoTkpPMlJIeF9Ua01fR1oyT0QxY3I1dVFEbzVkZGVjMkd6NDFWTWh5eEpVUXJGSi1YRzRHdEdPdTNfTTFfMl9ydDlCMWtNSXlZTmFQdkY?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T12:49:22+00:00", "published_display": "15 Jul 2026 12:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBIT forward of Zhejiang Ausun Pharmaceutical Co., Ltd. Class A \u2013 SSE:603229", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxPUWNHWnRpUXZBSnZrcjBzc2JDc3BiOG0wVEUtcWtfZWpYbFdRNEFEazU2Ylg2T0ZkcE41ajk3cVlQUUxHVGtIdDVfR0d3Ny1hclh0RTBHeFNhT1RaQ3NLUEtNVzJ6azlPRlM3WThJQkFPbnBqb0hwUEEyWlZkVUtkQml5WVVmazFnVS04OG9SeW1OSWs0anVrR0RmUjFQSVRycGtvWC01bEVoQQ?oc=5", "source_name": "TradingView", "published_at": "2026-07-16T00:41:52+00:00", "published_display": "16 Jul 2026 00:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to sales forward of Zhejiang Ausun Pharmaceutical Co., Ltd. Class A \u2013 SSE:603229", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxQWno3X1VkbFRtckZfS2xRNHdEWUUyNDZmZzJDbkVKWm1OalQtT0NDb2wwRFlCR2pZRHBWbHlWUXBxTmRDbTVFX1VZZjMwSVVoTkpPMlJIeF9Ua01fR1oyT0QxY3I1dVFEbzVkZGVjMkd6NDFWTWh5eEpVUXJGSi1YRzRHdEdPdTNfTTFfMl9ydDlCMWtNSXlZTmFQdkY?oc=5", "source_name": "TradingView", "published_at": "2026-07-15T12:49:22+00:00", "published_display": "15 Jul 2026 12:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 56, "total_relevant": 2, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 2, "score": 50, "total": 2, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 75, "events": [{"event": "general", "label": "Market update", "weight": 1.1, "count": 2}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 8.1, "latest_week": "2026-07-17", "one_week_move": 0.9, "four_week_move": 0.5, "twelve_week_move": -20.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -1.268095, "market_dynamics_buy_signal": false, "relative_strength": -14.240391, "fair_value_gap": -9.0, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 46.6102, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "+0.9% over one week, +0.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 46, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 2}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "75/100 classification confidence."}, {"label": "Company focus", "value": "2", "tone": "neutral", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+0.9% over one week, +0.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBIT forward of Zhejiang Ausun Pharmaceutical Co., Ltd. Class A \u2013 SSE:603229"}], "updated_at": "2026-07-22T01:00:55.609325+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}